[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100547287":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":41,"responsibleParty":57,"collaborators":26,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":26,"eligibilityCriteria":66,"healthyVolunteers":67,"sex":68,"minAge":69,"maxAge":26,"enrollmentInfo":70,"targetDuration":26,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":26,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Rigshospitalet, Denmark","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ropivacaine group","EXPERIMENTAL","Ropivacaine 5 mg\u002Fml 20ml",[13],"Drug: Ropivacaine 5mg\u002Fml 20ml",{"label":15,"type":16,"description":17,"interventionNames":18},"Saline group","PLACEBO_COMPARATOR","NaCl 0.9%",[19],"Drug: Saline 0.9%",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Ropivacaine 5mg\u002Fml 20ml","administered in a pericapsular nerve group (PENG) block",[9],null,{"type":22,"name":28,"description":24,"armGroupLabels":29,"otherNames":26},"Saline 0.9%",[15],[31],{"name":32,"affiliation":33,"role":34},"Matias Vested, Md, PhD","Rigshospitalet University of Copenhagen","STUDY_CHAIR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Matias Vested","CONTACT","+4535455747","matias.vested@regionh.dk",[42],{"facility":43,"status":44,"city":45,"state":26,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Rigshospitalet","RECRUITING","Copenhagen","2100","Denmark","DK",{"type":50,"coordinates":51},"Point",[52,53],12.56553,55.67594,{"lat":53,"lon":52},[56],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},{"type":58,"investigatorFullName":37,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"SPONSOR_INVESTIGATOR","MD PhD","100547287","phase-4-investigating-the-effect-of-pericapsular-nerve-group-peng-block-on-postoperative-pain-after-peri-acetabular-osteotomy-100547287",false,"NCT06406010","Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy","A Blinded Randomized Study Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy","Inclusion Criteria:\n\n1. Patients ≥ 18 years old\n2. Informed consent\n3. Scheduled for periacetabular osteotomy under general anesthesia with intubation\n4. American Society of Anesthesiologists (ASA) physical status classification I to III\n5. Can read and understand Danish\n\nExclusion Criteria:\n\n1. Known allergy to ropivacaine\n2. Daily use of opioids, gabapentin or tricyclic antidepressant (regardless of dose) within the last four weeks prior to surgery\n3. Contraindications to Celocoxib, NSAIDs or paracetamol",true,"ALL","18 Years",{"count":71,"type":72},90,"ESTIMATED","INTERVENTIONAL",[75],"PHASE4","The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg\u002FmL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).",[78],"Anesthesia, Local","2025-08-19",{"date":81,"type":82},"2025-08-26","ACTUAL",{"date":84,"type":82},"2024-08-19",{"date":86,"type":72},"2026-03-01",{"name":37,"class":6},1]